News

Video

Common Manifestations of Congenital Plasminogen Deficiency and Their Impact on Patient Outcomes

Per Morten Sandset, MD, of the University of Oslo and Oslo University Hospital, describes common manifestations of congenital plasminogen deficiency and their impact on patient outcomes.

Pharmacy Times® interviewed Per Morten Sandset, MD, a principal investigator and professor in the Department of Haematology and the Research Institute of Internal Medicine at the University of Oslo and Oslo University Hospital, on his presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses research conducted to investigate the successful pregnancy of a patient with infertility due to congenital plasminogen deficiency who was treated with intravenous plasminogen replacement therapy.

In this video, Sandset describes common manifestations of congenital plasminogen deficiency and their impact on patient outcomes.

Related Videos
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Image Credit: © Cavan - stock.adobe.com
Image Credit: © utah51 - stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com
Image Credit: © RandyJay - stock.adobe.com
Image Credit: © nimito - stock.adobe.com
WCLC, lung cancer, NSCLC
MARIPOSA Study: Long-Term Outcomes and Next Steps for Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC